CincyTech

CincyTech is a venture capital firm based in Cincinnati, Ohio, focusing on seed-stage investments to drive economic growth and innovation in the Midwest. Founded in 2006, CincyTech has invested in over 140 companies, particularly in the healthcare, technology, and life sciences sectors. Some of their notable investments include Enable Injections, which raised $215 million in Series C funding for their wearable drug delivery devices, and Genetesis, a company that secured $17.5 million to advance their Cardioflux diagnostic imaging platform. Other prominent portfolio companies include ReadySet Surgical, Standard Bariatrics, and NaviStone, which leverage innovative solutions in their respective fields. In 2022, CincyTech reported a record $391 million in co-investments in its portfolio companies, reflecting its significant impact on the regional economy. The firm continues to focus on partnering with visionary founders to transform ideas into world-class companies, supporting them with strategic guidance and access to a robust network of co-investors.